Pramod K. Srivastava, M.D., Ph.D.
University of Connecticut School of Medicine
Dr. Pramod Srivastava is professor of immunology at the University of Connecticut School of Medicine, where he is also director of the Center for Immunotherapy of Cancer and Infectious Diseases. He holds the Physicians Health Services Chair in Cancer Immunology at the University. Professor Srivastava is the scientific founder of Agenus (formerly Antigenics). He serves on the Scientific Advisory Council of the Cancer Research Institute and was a member of the Experimental Immunology Study Section of the National Institutes of Health of the U.S. Government (1994-1999). He serves presently on the Board of Directors of two privately held companies: Ikonisys (New Haven, Conn.) and CambriaTech (Lugano, Switzerland). In 1997, he was inducted into the Roll of Honor of the International Union Against Cancer and was listed in Who's Who in Science and Engineering. He also serves as deputy editor-in-chief of CRI's open access journal Cancer Immunity, and is among the 20 founding members of the Academy of Cancer Immunology.
Dr. Srivastava obtained his bachelor's degree in biology and chemistry and a master's degree in botany (paleontology) from the University of Allahabad, India. He then studied yeast genetics at Osaka University, Japan. He completed his Ph.D. in biochemistry at the Center for Cellular and Molecular Biology, Hyderabad, India, where he began his work on tumor immunity, including identification of the first proteins that can mediate tumor rejection. He trained at Yale University and Sloan-Kettering Institute for Cancer Research. Dr. Srivastava has held faculty positions at the Mount Sinai School of Medicine and Fordham University in New York City.